Investor Diligence and Decision Support
We support VC/CVC teams, Private Equity, Hedge Funds, and other investors with decision-grade intelligence in BioPharma, HealthTech, and AI-enabled healthcare. From fast diligence to ongoing monitoring, we help you validate assumptions, surface risks early, and act with confidence.
From identifying emerging trends and hidden risks to supporting diligence and portfolio decisions, we deliver concise, actionable recommendations that create an edge.
Our work commonly includes:
- Landscape + diligence (science, commercial, competitive dynamics)
- Company/asset profile (TAM, segmentation, growth drivers, value proposition)
- Opportunity/risk assessment (red flags, catalysts, scenarios, mitigations)
- Custom research aligned to your thesis and timelines (deal-specific questions, thesis validation, monitoring)
Typical engagement modes:
- Diligence Sprint (5–10 business days)
- Monthly monitoring and brief updates
- Decision workshops and AI-powered wargaming when stakes are high
Don’t forget to check out our Lucid Diligence Briefs, delivering 60-second theses, questions to ask, red flags and catalysts to watch, linked to trending news.
Want to move faster on your next decision? Contact: info@lqventures.com
October 23, 2025
Rare Disease Video Recap—October 23rd 2025
October 23, 2025
Cardiovascular Today—October 23, 2025
October 23, 2025
Rare Disease Today—October 23, 2025
October 23, 2025
Cell and Gene Therapy Today—October 23, 2025
October 22, 2025
Lucid Diligence Brief: Ipsen to acquire ImCheck Therapeutics
October 22, 2025
Neuroscience Today—October 22, 2025
October 22, 2025
Immunology Video Recap—October 22, 2025
October 22, 2025
Immunology Today—October 22, 2025
October 22, 2025
Lucid Diligence Brief: Hologic acquisition by Blackstone and TPG
October 21, 2025
Lucid Diligence Brief: HealthVerity and Claritas Rx partnership
October 21, 2025
Obesity Today—October 21, 2025
October 21, 2025